Profil
Reina Benabou worked as the Head-Global Medical Product Evaluation at Pfizer Inc. from 2012 to 2013.
She then worked as the VP & Head-Global Medical Communications at Novartis Pharma AG from 2014 to 2016.
From 2018 to 2020, she served as the Chief Medical Officer & Senior Vice President at Cognivue, Inc. In 2020, she became the Chief Development Officer & Senior Vice President at BioXcel Therapeutics, Inc. Dr. Benabou holds a doctorate degree from the University of Montréal and the University of Sao Paulo.
Anciens postes connus de Reina Benabou
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 30/07/2021 |
Cognivue, Inc.
 Cognivue, Inc. Medical SpecialtiesHealth Technology Cognivue, Inc. provides health care systems for cognitive, cervical cancer, diabetes, cholesterol, colon cancer, etc. The firm product is Cognivue, which is used for the computerized test of cognitive function. The company is headquartered in Victor, NY. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Public Communications Contact | 01/01/2016 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2013 |
Formation de Reina Benabou
| University of Montréal | Doctorate Degree |
| University of Sao Paulo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Cognivue, Inc.
Cognivue, Inc. Medical SpecialtiesHealth Technology Cognivue, Inc. provides health care systems for cognitive, cervical cancer, diabetes, cholesterol, colon cancer, etc. The firm product is Cognivue, which is used for the computerized test of cognitive function. The company is headquartered in Victor, NY. | Health Technology |
